Correspondence 0001213900-24-054375 from OS Therapies Inc (OSTX)
OS Therapies Inc
Date: June 20, 2024 · CIK: 0001795091 · Accession: 0001213900-24-054375
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279839
Letter
June 20, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Jimmy McNamara, Esq.
Office of Life Sciences
Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-279839)
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated (the “Company”), this letter will serve to withdraw the request for acceleration of the above-referenced Registration Statement filed as correspondence via EDGAR on Tuesday, June 18, 2024.
The Company is no longer requesting that such Registration Statement be declared effective at 4:00 p.m., Eastern Time, on Thursday, June 20, 2024, and we hereby formally withdraw our request for acceleration of the effective date.
Thank you for your assistance.
Very truly yours,
/s/ Spencer G. Feldman
Spencer G. Feldman
cc: Paul A. Romness, MPH
June 20, 2024
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Jimmy McNamara, Esq.
Office of Life Sciences
Re: Withdrawal of Acceleration Request
OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-279839)
Ladies and Gentlemen:
OS Therapies Incorporated hereby withdraws the request for acceleration of the above-referenced Registration Statement filed as correspondence via EDGAR on Tuesday, June 18, 2024.
We are no longer requesting that such Registration Statement be declared effective at 4:00 p.m., Eastern Time, on Thursday, June 20, 2024, and we hereby formally withdraw our request for acceleration of the effective date.
Very truly yours,
OS Therapies Incorporated
Show Raw Text
CORRESP
1
filename1.htm
June 20, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.:
Jimmy McNamara, Esq.
Office of Life Sciences
Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-279839)
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated (the “Company”),
this letter will serve to withdraw the request for acceleration of the above-referenced Registration Statement filed as correspondence
via EDGAR on Tuesday, June 18, 2024.
The Company is no longer requesting that such Registration
Statement be declared effective at 4:00 p.m., Eastern Time, on Thursday, June 20, 2024, and we hereby formally withdraw our request for
acceleration of the effective date.
Thank you for your assistance.
Very truly yours,
/s/ Spencer G. Feldman
Spencer G. Feldman
cc: Paul A. Romness, MPH
June 20, 2024
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.:
Jimmy McNamara, Esq.
Office of Life Sciences
Re: Withdrawal of Acceleration Request
OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-279839)
Ladies and Gentlemen:
OS Therapies Incorporated hereby withdraws the
request for acceleration of the above-referenced Registration Statement filed as correspondence via EDGAR on Tuesday, June 18, 2024.
We are no longer requesting
that such Registration Statement be declared effective at 4:00 p.m., Eastern Time, on Thursday, June 20, 2024, and we hereby formally
withdraw our request for acceleration of the effective date.
Very truly yours,
OS Therapies Incorporated
By:
/s/ Paul A. Romness
Paul A. Romness
President and Chief Executive Officer